title: Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies.
authors.forename: Dario
authors.initials: D
authors.lastname: Cocito
authors.forename: Grazia
authors.initials: G
authors.lastname: Serra
authors.forename: Ilaria
authors.initials: I
authors.lastname: Paolasso
authors.forename: Diego A
authors.initials: DA
authors.lastname: Barilà
authors.forename: Leonardo
authors.initials: L
authors.lastname: Lopiano
authors.forename: Luigi
authors.initials: L
authors.lastname: Cattel
mesh_terms: D001327:Autoimmune Diseases / Q000191:economics* / Q000523:psychology / Q000628:therapy*; D002908:Chronic Disease; D003363:Cost Control; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006699:Home Care Services / Q000191:economics; D006801:Humans; D007116:Immunization, Passive / Q000191:economics* / Q000295:instrumentation; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D010523:Peripheral Nervous System Diseases / Q000191:economics* / Q000523:psychology / Q000628:therapy*; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000191:economics / Q000628:therapy; D011788:Quality of Life / Q000523:psychology*; D011795:Surveys and Questionnaires
chemical_list: D016756:Immunoglobulins, Intravenous